Trial Profile
A Study to Evaluate the Changes of Pulmonary Function Test (PFT) and Whether the Change of PFT is Associated with the Development of Non-infectious Pneumonitis in Patients with Metastatic Renal Cell Carcinoma Treated with Everolimus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions
- 16 Dec 2015 New trial record